Treatments

Moderna asks FDA to authorize its updated Covid booster shot

Submitted by mike kraft on

Moderna asks FDA to authorize its updated Covid booster shot Moderna asked the Food and Drug Administration to authorize its bivalent omicron Covid booster. YahooNews

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Government
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Regular physical activity may lessen Covid risks -- British study

Submitted by mike kraft on

Regular physical activity may lessen Covid risks, study finds The research suggested exercise could affect the severity of infection, rates of hospitalisation and death the Guardian

...

Country / Region Tags: 
Global
UK - London
United Kingdom
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Health
Pandemics
Public Health
Research
Social behavior
Problem, Solution, SitRep, or ?: 
Analysis

U.S. plan to stretch monkeypox vaccine supply already facing implementation problems

Submitted by mike kraft on

U.S. plan to stretch monkeypox vaccine supply already hitting hurdles The federal government's plans for fractional dosing of monkeypox vaccine assume that five doses can be extracted from a vial, but some local health officials are reporting that they can get only three or four doses. Helen Branswell STAT

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
Mpox
Treatments
Disease
Disease Prevention
Education
Health
Medical Personnel
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Pfizer's COVID vaccine 73.2% effective in kids under 5-- new data

Submitted by mike kraft on

Pfizer's COVID vaccine 73.2% effective in kids under 5, new data shows Pfizer Inc and BioNTech's vaccine was 73.2% effective in preventing COVID-19 among children aged 6 months through 4 years, new data from the companies showed on Tuesday, two months after the U.S. rollout of the shots began for that age group. Reuters Reuters

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Contagion
Data
Demographics
Disease
Disease Prevention
Health
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

U.S. CDC approves use of Novavax's COVID shot for adolescents

Submitted by mike kraft on

U.S. CDC recommends use of Novavax's COVID shot for adolescents The U.S. Centers for Disease Control and Prevention (CDC) on Monday signed off on the use of Novavax Inc's COVID-19 vaccine for adolescents aged 12 through 17. Reuters Reuters

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Demographics
Disease
Disease Prevention
Government
Health
Pandemics
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Pfizer seeks FDA approval of updated COVID vaccine booster retooled for Omcron

Submitted by mike kraft on

Pfizer seeks U.S. authorization for vaccine booster retooled for Omicron Pfizer Inc and German partner BioNTech said on Monday they had sought U.S. authorization for a COVID-19 vaccine booster retooled to target the Omicron variant, and would have doses available to ship immediately after regulatory clearance. Reuters Reuters

...

Country / Region Tags: 
Germany
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Government
Health
Medical Testing
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

U.S.: Overlapping emergencies strain the nation's public health workforce and threaten critical vaccination campaigns

Submitted by mike kraft on

Overlapping emergencies strain the nation's public health workforce and threaten critical vaccination campaigns After almost three years of contending with vaccine hesitancy, politics and a global pandemic, the nation's public health workers are frayed and leaving their posts. Now, these depleted agencies are being asked to tackle new threats like monkeypox without additional funding to handle them. Brenda Goodman, CNN Health CNN

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Mpox
Boosters
Treatments
Contagion
Disease
Disease Prevention
Government
Health
Hospitals
Medical Personnel
Mutations
Pandemics
Public Health
Scarcity
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Analysis: The difficulties in understanding and diagnosing long COVID

Submitted by mike kraft on

Are you among the 1 in 5 Americans with long COVID? Here’s what you need to know about how brain-foggy—and potentially dangerous—it is Experts are developing a better understanding of long COVID, including what it does to your energy levels, cognition, and even if it can be deadly. Fortune

...

It’s hard to attribute a symptom to a condition like long COVID when that condition has yet to be clearly defined, experts say. ...

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Demographics
Disease
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis

U.S. NIH plans first big clinical trials of treatments for long-term COVID-19

Submitted by mike kraft on

"Long COVID" response ramps up, with plans to test new treatments The research is one of several efforts by the Biden administration to address long-term symptoms that linger for some patients. YahooNews

...

The National Institutes of Health is now hoping to launch its first big clinical trials of potential treatments for patients experiencing long-term symptoms from COVID-19 as early as October, according to a top federal official overseeing the plans.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Contagion
Disease
Disease Prevention
Government
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

Who will be eligible for the upcoming Omicron-specific Covid booster shots

Submitted by mike kraft on

 

Omicron-specific Covid booster shots are just weeks away. Here’s who will—and won’t—be eligible

Newly updated Covid booster shots designed to target omicron’s BA.5 subvariant should be available within in the next three weeks. That begs an important question: Who’s going to be eligible to get them?

The short answer: Anyone ages 12 and up who has completed a primary vaccination series, a Centers for Disease Control and Prevention spokesperson tells CNBC Make It. It’s unlikely to matter whether you’ve received any other booster doses or not before, the spokesperson says — but if you’re unvaccinated, you won’t eligible for the updated formula until you complete a primary series with the existing Covid vaccines.

The longer answer is somewhat more complex, because it depends on which booster shots get approved and when. ...

 

 

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Government
Mutations
Pandemics
Public Health
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Treatments